Government of Canada
Symbol of the Government of Canada

Chemical Substances in Batch 9 of the Challenge

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

On March 14, 2009, the Minister of the Environment and the Minister of Health released a Notice in the Canada Gazette for the ninth group of substances identified under the Challenge, entitled: Notice of ninth release of technical information relevant to substances identified in the Challenge. Industry and interested stakeholders are invited to submit any information that may be used to inform risk assessment and to develop and benchmark best practices for risk management and product stewardship.

For each substance in Batch 9, we invite you to familiarize yourself with the following:

Substance Profiles for Batch 9 Substances

A. Substances identified as persistent, bioaccumulative, and inherently toxic to non-human organisms and believed to be in commercial use in Canada
CAS No. Chemical Substance
Public Summary
Substance Profile

* Substances for which no response was received to the notice published in the Canada Gazette, Part I, Vol. 140, No. 9, under section 71 of the Canadian Environmental Protection Act, 1999, on March 4, 2006, but for which stakeholders indicated in their Declaration of Non-Engagement forms an interest in the substances.

** Substance added to the Challenge as a result of information received during public comments on the December 9, 2006 Notice with respect to the draft screening assessment report on 148 PBiT substances published in the Canada Gazette, Part I, along with a notice of intent to amend the Domestic Substances List to apply the Significant New Activity provisions under subsection 81(3) of the Canadian Environmental Protection Act, 1999 to these 148 substances.

475-71-8* Benzo[h]benz[5,6]acridino[2,1,9,8-klmna]acridine-8,16-dione Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
509-34-2 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-bis(diethylamino)- Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
1326-05-2 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 2',4',5',7'-tetrabromo-3',6'-dihydroxy-, lead salt Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
2134-15-8* Benzoic acid, 2,3,4,5-tetrachloro-6-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)- Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
2379-74-0 Benzo[b]thiophen-3(2H)-one, 6-chloro-2-(6-chloro-4-methyl-3-oxobenzo[b]thien-2(3H)-ylidene)-4-methyl- Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
7328-97-4 Oxirane, 2,2' ,2'' ,2''' -[1,2-ethanediylidenetetrakis(4,1-phenyleneoxymethylene)]tetrakis- Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
14295-43-3* Benzo[b]thiophen-3(2H)-one, 4,7-dichloro-2-(4,7-dichloro-3-oxobenzo[b]thien-2(3H)-ylidene)- Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
38465-55-3* Nickel, bis[1-[4-(dimethylamino)phenyl]-2-phenyl-1,2-ethenedithiolato(2-)-S,S']- Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
41556-26-7 Decanedioic acid, bis(1,2,2,6,6-pentamethyl-4-piperidinyl) ester Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
58161-93-6* Benzoic acid, 4-[1-[[(2,4-dichlorophenyl)amino]carbonyl]-3,3-dimethyl-2-oxobutoxy]- Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
64338-16-5 7-Oxa-3,20-diazadispiro[5.1.11.2]heneicosan-21-one, 2,2,4,4-tetramethyl- Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
71032-95-6** 2-Naphthalenesulfonic acid, 7-[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[[4-(phenylazo)phenyl]azo]-, monoacetate (salt) Next link will take you to another Web site HTML
Next link will take you to another Web site PDF


B. Substances identified as a high hazard to humans and presenting a high likelihood of exposure to individuals in Canada
CAS No. Chemical Substance
Public Summary
Substance Profile
88-12-0 2-Pyrrolidinone, 1-ethenyl- Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
93-15-2 Benzene, 1,2-dimethoxy-4-(2-propenyl)- Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
1309-64-4 Antimony oxide (Sb2O3) Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
1314-62-1 Vanadium oxide (V2O5) Next link will take you to another Web site HTML
Next link will take you to another Web site PDF
7758-01-2 Bromic acid, potassium salt Next link will take you to another Web site HTML
Next link will take you to another Web site PDF

Mandatory Section 71 Survey Notice

The following Notice, issued under section 71 of the Canadian Environmental Protection Act, 1999, entitled: Notice with respect to Batch 9 Challenge substances applies to the 17 substances in the ninth group identified under the Challenge.

Every person to whom the Notice applies must comply with the Notice by no later than 3:00 p.m. EDT, July 14, 2009. Please note that under subsection 71(4) of the Act extensions for a maximum of two months may be granted in some cases on written request. To apply for an extension, a written request and justification must be received by the Minister of the Environment prior to the deadline.

Voluntary Questionnaire

In addition, Industry and interested stakeholders are also invited to submit, within six months (on or before September 10, 2009), further information regarding the scientific properties of these substances, or best management practices associated with the use of these substances that might contribute to improved decision-making.  Information on the type of information that could be submitted, and logistics for submitting information is detailed in the Challenge Questionnaire and related Guidance Document below.

Timelines

Date Activity
14 March 2009 Release of "batch 9" of the Challenge and the accompanying technical documents.
14 July 2009 Deadline for submission of information under the section 71 notice on "batch 9" substances (if no extension granted).
10 September 2009 Deadline for submission of additional information by interested stakeholders, including on the extent and nature of the management/stewardship of "batch 9" substances.
Anticipated on 19 December 2009 If no information received:
Publication in Canada Gazette and start of 60-day public comment period on (a) the draft screening assessment, (b) the proposal to pursue one of the measures as specified under subsection 77(2) and (c) the risk management scope documents.
Anticipated on 20 March 2010 If specified information is received:
Publication in Canada Gazette and start of 60-day public comment period on (a) the draft screening assessment, (b) the new information received, (c) the proposal to pursue one of the measures as specified under subsection 77(2) and (d) the risk management scope documents.
Anticipated on 19 June 2010 When no information is received during challenge period:
Publication in Canada Gazette of final assessment decision under subsection 77(6), release of Government's proposed risk management approach document, and start of 60-day public comment period on the proposed risk management approach document.
Anticipated on 18 September 2010 When information is received during challenge period:
Publication in Canada Gazette of final assessment decision under subsection 77(6), release of Government's proposed risk management approach document, and start of 60-day public comment period on the proposed risk management approach document.

Stakeholder Information Workshops on the Challenge

The Government of Canada regularly hosts stakeholder information workshops to help further explain the Challenge, the associated documentation and how to participate.

For information on the latest stakeholder information workshops on the Challenge, please click on the following link:

Contact Information

Comments or questions should be sent to:

DSL Surveys Coordinator
Chemicals Management Plan
Gatineau, QC K1A 0H3

E-mail: DSL.surveyco@ec.gc.ca
Telephone: 1-800-567-1999 (in Canada) or 819-953-7156
Fax: 819-953-7155